United States

People: AfroCentric Investment Corporation Ltd (ACTJ.J)

ACTJ.J on Johannesburg Stock Exchange

20 Oct 2017
Change (% chg)

9.00 (+1.41%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Saunders, Brenton 

Mr. Brenton L. Saunders is Chairman of the Board, President, Chief Executive Officer of the Company. He joined the Board of Directors in July 2014 and began serving as our Chairman of the Board in October 2016. Mr. Saunders is Chairman, President and Chief Executive Officer of Allergan plc. He previously served as Chief Executive Officer and President of Forest Laboratories, Inc. and had served as a Director of Forest beginning in 2011. Prior to that, he served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held a number of leadership positions at Schering-Plough, including the position of President of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Mr. Saunders was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Mr. Saunders began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Mr. Saunders is a member of the Business Council and PhRMA.

Basic Compensation

Total Annual Compensation, USD 3,963,420
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 175,603
Fiscal Year Total, USD 4,139,030

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --